Teva Johnstone on gender, censorship and ideological capture
Teva Announces Fall 2023 Collection
Teva and MODAG collaborate on licensing a drug candidate for neurodegenerative diseases - Innovations- und Gründerzentrum Biotechnologie IZB
Teva and Biolojic enter antibody license deal
US states accuse Teva and other drugmakers of colluding to inflate prices over 1,000%
Teva Pharmaceuticals expands strategic partnership with Alvotech
Teva Defeats Patent Infringement Claims on Endocrine Drug | New Jersey Law Journal
Teva Likes Biosimilar Licensing Deals As It Cuts Full-Year Sales Guidance :: Generics Bulletin
Teva Pharmaceutical Industries Ltd's (ADR) (TEVA) GmbH and Alder BioPharmaceuticals Form Global License Agreement
Teva and Biolojic Design Announce Exclusive License Agreement for the Development of a Therapeutic Antibody for Atopic Dermatitis and Asthma | Business Wire
Teva Celebrates Pride with an Expansive Collection and Donation to the Human Rights Campaign Foundation
Teva, Stance for Collab for Capsule Collection | License Global
Alkermes grants Teva license to launch generic Vivitrol in 2027
Teva quits brand lobby PhRMA, in line to lead generic lobby AAM - STAT
Teva's Q3 triumph: 7% revenue surge propelled by Austedo and Ajovy
Teva Pharmaceuticals Found Liable For Opioid Crisis by Jury, Trial Will Determine Penalty
Teva announces capsule collaboration with Opening Ceremony - Brand License
In re Papst Licensing Digital Camera Litig.: Claim Construction in the Wake of Teva
Teva licenses rights to Biolojic's BD9 for atopic dermatitis and asthma | BioWorld